Alpha 2.0
Login Register
» Authors » Lucy Cook

Lucy Cook

Explore the profile of Lucy Cook including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 259
Followers 0
Related Specialties
Hematology
General Medicine
Top 10 Co-Authors
Peter R Lewis
Graham P Taylor
Carolina Rosadas
Katia Senna
Kikkeri N Naresh
Adele Caterino-de-Araujo
Kate Cwynarski
Maria Fernanda Rios Grassi
Olivier Hermine
Dima El-Sharkawi
Published In
Commun Dis Intell Q Rep
Lancet Glob Health
Br J Haematol
Curr Opin Oncol
J Psychosom Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Women living with HTLV-1 should have the opportunity to make informed decisions on prevention of mother-to-child transmission
Rosadas C, Senna K, da Costa M, Assone T, Casseb J, Nukui Y, et al.
Lancet Glob Health . 2023 Jul; 11(8):e1181. PMID: 37474224
No abstract available.
2.
A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
El-Sharkawi D, Sud A, Prodger C, Khwaja J, Shotton R, Hanley B, et al.
Blood Cancer J . 2023 Apr; 13(1):54. PMID: 37072385
No abstract available.
3.
Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model
Rosadas C, Senna K, da Costa M, Assone T, Casseb J, Nukui Y, et al.
Lancet Glob Health . 2023 Apr; 11(5):e781-e790. PMID: 37061315
Background: Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes severe diseases, such as aggressive cancer or progressive neurological disease. HTLV-1 affects mainly people in areas with...
4.
HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management
Wolf S, Vercruyssen M, Cook L
Curr Opin Oncol . 2022 Jul; 34(5):446-453. PMID: 35880453
Purpose Of Review: Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature T-cell malignancy that arises in approximately 5% of carriers of human T-lymphotropic virus type 1 (HTLV-1), but this risk...
5.
A Review of the Prevention of Mother-to-Child Transmission of Human T-Cell Lymphotrophic Virus Type 1 (HTLV-1) With a Proposed Management Algorithm
Barr R, Drysdale S, Boullier M, Lyall H, Cook L, Collins G, et al.
Front Med (Lausanne) . 2022 Jul; 9:941647. PMID: 35872787
Human T cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that is endemic in a number of regions across the world. There are an estimated 5-10 million people...
6.
Hyposplenism in adult T-cell leukemia/lymphoma
Cook L, Al-Yousuf H, Mohamedbhai S, Bain B
Am J Hematol . 2022 Mar; 97(7):966-967. PMID: 35338669
No abstract available.
7.
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline
Fox C, AHearne M, Pettengell R, Dearden C, El-Sharkawi D, Kassam S, et al.
Br J Haematol . 2021 Nov; 196(3):507-522. PMID: 34811725
No abstract available.
8.
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, et al.
Trials . 2021 Apr; 22(1):270. PMID: 33845867
Objectives: The primary objective of MATIS is to determine the efficacy of ruxolitinib (RUX) or fostamatinib (FOS) compared to standard of care (SOC) with respect to reducing the proportion of...
9.
Arsenic trioxide (AsO) as a maintenance therapy for adult T cell leukemia/lymphoma
Marcais A, Cook L, Witkover A, Asnafi V, Avettand-Fenoel V, Delarue R, et al.
Retrovirology . 2020 Mar; 17(1):5. PMID: 32199462
Background: Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature lymphoid proliferation associated with poor prognosis. Standard of care includes chemotherapy and/or the combination of zidovudine and interferon-alpha. However, most patients...
10.
Mogamulizumab investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma
Phillips A, Fields P, Hermine O, Ramos J, Beltran B, Pereira J, et al.
Haematologica . 2018 Dec; 104(5):993-1003. PMID: 30573506
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II...